- Capital Cube•7 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Pacira Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to PCRX-US. Comparing the performance and risk of Pacira Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Pacira Pharmaceuticals, Inc. : July 21, 2016 appeared first on CapitalCube.
- 24/7 Wall St.•last month
Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.
Pacira Pharmaceuticals, Inc.NasdaqGS
After hours: 37.470.00 (0.00%) as of 4:55 PM EDT
|Bid||32.00 x 2000|
|Ask||46.00 x 100|
|52wk Range||31.08 - 80.25|
|Day's Range||36.55 - 37.67|
|Avg Vol (3m)||920,614|
As of 4:00 PM EDT. Market closed.